Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

G20 must lead world by addressing climate change, working towards universal healthcare: Prabhu

by AIP Online Bureau | Nov 27, 2020 | Eco/Invest/Demography, International News, Pandemic

The future of the world is also the responsibility of the G20, and the grouping of developed and emerging economies must guide and lead the world by addressing climate change and working towards universal healthcare, India's Sherpa to G20 Suresh Prabhu said on...

Europe’s drugs watchdog expects first marketing application for coronavirus vaccine in days

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

BRUSSELS: Europe's drugs watchdog said on Thursday it expects to receive the first application for conditional marketing approval for a Covid-19 vaccine "in the coming days", the latest step towards making a shot available outside the United States. The...

Covid vaccine rush in China raises fears of booming black market

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

, Before a planned trip to the U.S., Cheng wanted to get vaccinated against Covid-19. To do so, he asked a friend working at a cold-chain logistics company in southeast China to pretend he was employed by the firm, allowing Cheng access to one of the country’s...

The biggest threat to Covid-19 vaccination could be fake news and misinformation

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic, Risk Management

PARIS: As early as February, with the global pandemic spreading fast, the World Health Organization issued a warning about an "infodemic", a wave of fake news and misinformation about the deadly new disease on social media. Now with hopes hanging on Covid-19...

CEO says AstraZeneca likely to run new global Covid vaccine trial: Report

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, International News

  AstraZeneca is likely to run an additional global trial to assess the efficacy of its Covid-19 vaccine, its chief executive Pascal Soriot was quoted as saying on Thursday after questions over the results from its late-stage study. Instead of adding the...

Aviation bodies seek airport slots waiver for much of 2021

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, International News

Global aviation heavyweights led by airline body IATA are pushing to suspend airport slot access rules until October 2021, a document seen by Reuters showed, while giving some ground to budget carriers angered by measures they deem anti-competitive. The draft proposal...

Asset base, subscribers under NPS rising: PFRDA

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Indian News, Pension & Social Security

Kolkata: The Pension Fund Regulatory Development Authority (PFRDA) on Thursday said that the asset base and the number of subscribers under the National Pension System (NPS) have been rising. PFRDA Chairman Supratim Bandyopadhyay said that even during the pandemic,...

Cyclone Nivar slams into southern India causing five deaths

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Indian News

  CHENNAI, A severe cyclone slammed into India’s southern coast early on Thursday, killing at least five people and uprooting trees and power lines. Cyclone Nivar made landfall near the city of Puducherry, located near the southern state of Tamil Nadu, with...

Skoda India’s plea to quash FIR for alleged use of cheat device dismissed

by AIP Online Bureau | Nov 26, 2020 | Indian News, Risk Management, Technology

New Delhi: The Supreme Court Thursday dismissed a plea by German car maker Skoda Auto Volkswagen India challenging an FIR registered in Uttar Pradesh by a customer over the alleged use of cheat device in its diesel car. A bench of Chief Justice S A Bobde and Justices...

AstraZeneca faces more Covid-19 vaccine questions after manufacturing error

by AIP Online Bureau | Nov 26, 2020 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  AstraZeneca Plc and the University of Oxford face mounting questions about their Covid-19 vaccine trial results after acknowledging a manufacturing error. While an announcement earlier this week by Astra and Oxford showed their shot was 70 per cent effective on...
« Older Entries
Next Entries »

Recent Posts

  • Gemini hacked three companies in first known breakout by Google’s AI
  • Late dinners, long commutes weigh on urban Indians’ wellness: EYVA report
  • PM Modi highlights climate inequality: Developed nations emit 6 times more per capita than India
  • Hong Kong sets out initiatives to secure long-term development of pillar industries
  • Majority of digital infra stakeholders faced material disruption in 5 yrs: Economist Enterprise–FM report

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy